Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: A meta-analysis

Lupus

Volumn 20, Issue 9, 2011, Pages 945-951

  Pan, H F ^a   Leng, R X ^a   Ye, D Q ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

autoimmune disease; IL 18; meta analysis; susceptibility

Indexed keywords

INTERLEUKIN 18;

ARTICLE; AUTOIMMUNE DISEASE; CROHN DISEASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; MESH HEADING; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC ERROR; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-18; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 80052533822     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311400114     Document Type: Article

References (50)

1. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med. 2001 ; 7: 899-905 (Pubitemid 32756426)
2. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol. 2001 ; 2: 802-809
3. Tait KF, Marshall T, Berman J, et al. Clustering of autoimmune disease in parents of siblings from the type 1 diabetes Warren repository. Diabet Med. 2004 ; 21: 358-362 (Pubitemid 38519672)
4. Becker KG. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?. Diabetes. 1999 ; 48: 1353-1358 (Pubitemid 29297295)
5. Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur Cytokine Netw. 2006 ; 17: 224-252
6. Neumann D, Del Giudice E, Ciaramella A, et al. Lymphocytes from autoimmune MRL lpr/lpr mice are hyperresponsive to IL-18 and overexpress the IL-18 receptor accessory chain. J Immunol. 2001 ; 166: 3757-3762 (Pubitemid 32224899)
7. Esfandiari E, McInnes IB, Lindop G, et al. A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol. 2001 ; 167: 5338-5347 (Pubitemid 33009773)
8. Faust J, Menke J, Kriegsmann J, et al. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum. 2002 ; 46: 3083-3095 (Pubitemid 35315904)
9. Bossù P, Neumann D, Del Giudice E, et al. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci U S A. 2003 ; 100: 14181-14186 (Pubitemid 37499211)
10. Bossù P, Del Giudice E, Ciaramella A, et al. IL-18 and IL-18 receptors in the development of autoimmunity. Eur Cytokine Netw. 2000 ; 11: 515-516
11. Wildbaum G, Youssef S, Grabie N, Karin N. Neutralizing antibodies to IFN-γ-inducing factor prevent experimental autoimmune encephalomyelitis. J Immunol. 1998 ; 161: 6368-6374 (Pubitemid 28536013)
12. Zaccone P, Phillips J, Conget I, et al. IL-18 binding protein fusion construct delays the development of diabetes in adoptive transfer and cyclophosphamide-induced diabetes in NOD mouse. Clin Immunol. 2005 ; 115: 74-79 (Pubitemid 40616172)
13. Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics. 1998 ; 51: 161-163 (Pubitemid 28373391)
14. Ide A, Kawasaki E, Abiru N, et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun. 2004 ; 22: 73-78 (Pubitemid 38050215)
15. Novota P, Kolostova K, Pinterova D, et al. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett. 2005 ; 96: 247-251 (Pubitemid 39600782)
16. Martin RJ, Savage DA, Carson DJ, et al. Interleukin 18 promoter polymorphisms are not strongly associated with type I diabetes in a UK population. Genes Immun. 2005 ; 6: 171-174 (Pubitemid 40439545)
17. Szeszko JS, Howson JM, Cooper JD, et al. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Diabetes. 2006 ; 55: 559-562 (Pubitemid 43343290)
18. Mojtahedi Z, Naeimi S, Farjadian S, et al. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med. 2006 ; 23: 235-239
19. Dong GP, Yu ZS, Liang L, et al. IL-18 gene promoter -137C/G and -607C/A polymorphisms in Chinese Han children with type 1 diabetes mellitus. Int J Immunogenet. 2007 ; 34: 75-79 (Pubitemid 46435095)
20. Gracie JA, Koyama N, Murdoch J, et al. Disease association of two distinct interleukin-18 promoter polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun. 2005 ; 6: 211-216 (Pubitemid 40645564)
21. Huang XZ, Zhuang JH, Ren YG, et al. Association of interleukin-6 and interleukin-18 gene polymorphism with rheumatoid arthritis in Guangdong Han population. Nan Fang Yi Ke Da Xue Xue Bao. 2007 ; 27: 1661-1664
22. Pawlik A, Kurzawski M, Czerny B, et al. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens. 2006 ; 67: 415-418
23. Xu Q, Tin SK, Sivalingam SP, et al. Interleukin-18 promoter gene polymorphisms in Chinese patients with systemic lupus erythematosus: Association with CC Genotype at position -607. Ann Acad Med Singapore. 2007 ; 36: 91-95 (Pubitemid 46640258)
24. Lin YJ, Wan L, Lee CC, et al. Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun. 2007 ; 8: 302-307 (Pubitemid 46893958)
25. Lan Y, Wei YS, Tang XS, et al. Association of interleukin-18 gene polymorphism with genetic susceptibility to systematic lupus erythematosus in Guangxi Zhuang population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 ; 25: 434-437
26. Hirankarn N, Tangwattanachuleeporn M, Wongpiyabovorn J, et al. Association of IL-18 gene polymorphism (-137C) with arthritis manifestations in SLE: combined effect with IFN gamma gene polymorphism (+874A). Clin Rheumatol. 2009 ; 28: 219-223
27. Sánchez E, Palomino-Morales RJ, Ortego-Centeno N, et al. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet. 2009 ; 18: 3739-3748
28. Glas J, Török HP, Tonenchi L, et al. Association of polymorphisms in the interleukin-18 Gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflamm Bowel Dis. 2005 ; 11: 1031-1037 (Pubitemid 41682558)
29. Aizawa Y, Sutoh S, Matsuoka M, et al. Association of interleukin-18 gene single nucleotide polymorphisms with susceptibility to inflammatory bowel disease. Tissue Antigens. 2005 ; 65: 88-92 (Pubitemid 40179667)
30. Takagawa T, Tamura K, Takeda N, et al. Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis. 2005 ; 11: 1038-1043 (Pubitemid 41682559)
31. Ide A, Kawasaki E, Abiru N, et al. Association of interleukin-18 gene promoter polymorphism in type 1 diabetes and autoimmune thyroid disease. Ann N Y Acad Sci. 2003 ; 1005: 436-439 (Pubitemid 38507801)
32. Pawlik A, Kurzawski M, Drozdzik M, et al. Interleukin-18 gene (IL18) promoter polymorphisms in patients with rheumatoid arthritis. Scand J Rheumatol. 2009 ; 38: 159-165
33. Chen DY, Hsieh CW, Chen KS, et al. Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus. 2009 ; 18: 29-37
34. Hiromatsu Y, Mukai T, Kaku H, et al. IL-18 gene polymorphism confers susceptibility to the development of anti-GAD65 antibody in Graves' disease. Diabet Med. 2005 ; 23: 211-215
35. Kretowski A, Mironczuk K, Karpinska A, et al. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes. 2002 ; 51: 3347-3349 (Pubitemid 35246985)
36. Sivalingam SP, Yoon KH, Koh DR, Fong KY. Single nucleotide polymorphisms of the interleukin-18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens. 2003 ; 62: 498-504 (Pubitemid 37475997)
37. Rueda B, González-Gay MA, Mataran L, et al. Interleukin-18- promoter polymorphisms are not relevant in rheumatoid arthritis. Tissue Antigens. 2005 ; 65: 544-548 (Pubitemid 40776303)
38. Woo JH, Seong SS, Yooa DH. Association of interleukin-18 polymorphisms with adult-onset Still's disease in Korea. J Rheumatol. 2007 ; 34: 1637-1639
39. Mukai T, Hiromatsu Y, Ichimura M, et al. Lack of association of interleukin-18 gene polymorphisms with susceptibility of Japanese populations to Graves' disease or Graves' ophthalmopathy. Thyroid. 2006 ; 16: 243-248
40. Heinzmann A, Gerhold K, Ganter K, et al. Association study of polymorphisms within interleukin-18 in juvenile idiopathic arthritis and bronchial asthma. Allergy. 2004 ; 59: 845-849 (Pubitemid 39005825)
41. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001 ; 112: 146-152
42. Chen DY, Chen YM, Chen HH, et al. Functional association of interleukin 18 gene -607 (C/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease. J Rheumatol. 2009 ; 36: 2284-2289
43. Cochran WG. The combination of estimates from different experiments. Biometrics. 1954 ; 10: 101-129
44. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 ; 21: 1539-1558 (Pubitemid 34746062)
45. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003 ; 327: 557-560 (Pubitemid 37088507)
46. Torres O, Palomino-Morales R, Miranda-Filloy JA, et al. IL-18 gene polymorphisms in Henoch-Schönlein purpura. Clin Exp Rheumatol. 2010 ; 28: 114-114
47. Palomino-Morales RJ, Vazquez-Rodriguez TR, Torres O, et al. Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis. Arthritis Res Ther. 2010 ; 12: R51 - R51
48. Wong CK, Li EK, Ho CY, Lam CW. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology. 2000 ; 39: 1078-1081
49. Amerio P, Frezzolini A, Abeni D, et al. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, proinflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines. Clin Exp Rheumatol. 2002 ; 20: 535-538 (Pubitemid 34846629)
50. Bresnihan B, Roux-Lombard P, Murphy E, et al. Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis. Ann Rheum Dis. 2002 ; 61: 726-729 (Pubitemid 34787712)